
John F. Engelhardt, Ph.D., is a leading expert in the area of submucosal gland biology, as well as in gene therapy of cystic fibrosis and other genetic diseases. He directs the center for Gene Therapy of Cystic Fibrosis and Other Genetic Diseases and is an associate professor of anatomy and cell biology at the University of Iowa. Over the past 8 years, Dr. Englehardt has published 57 research articles in peer-reviewed journals. He currently is principle investigator of five National Institutes of Health grants, including one for a large cystic fibrosis center, and has two grants from the Cystic Fibrosis Foundation. He has served as an ad hoc reviewer for over 10 scientific journals and currently is a member of a NIH study section. Over the past five years, he has mentored five graduate students and nine postdoctoral associates. About the lecture"Gene Therapy with DNA viruses in the 21st century: A walk through the past and look into the future." Studies evaluation mechanisms of adeno-associated virus transduction have uncovered several key features which will greatly increase the utility of this vector system for gene therapy of inherited diseases. Although gene therapy for inherited and acquired disorders had exploded in the last decade, the application of gene therapeutic approaches for transient pathological conditions resulting from environmental stress is just beginning to be recognized." Quoted from the 1999 Philip C. and Ethel F. Ashby Lecture Announcement Brochure. |